Intervention

Acetazolamide

ClinicalTrials.gov intervention label

Clinical trials34
Recruiting7
Common conditions25
Lead sponsors shown15

Clinical trials

34 shown
Add-on Diuretics in Acute Decompensated Heart FailureNCT07372040 · 2026-02-01
RECRUITING
Venous Stenting Evaluation in Patients With Intracranial Hypertension Under Long-term AcetazolamideNCT06945848 · 2026-01-05
RECRUITING
Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Acute Decompensated Heart FailureNCT07199088 · 2025-10-11
RECRUITING
Optimal Diuretic Therapies for Acute Heart Failure With Volume OverloadNCT06166654 · 2024-09-05
RECRUITING
Acetazolamide in Persons With Type 1 Diabetes - Crossover TrialNCT06981234 · 2024-08-14
RECRUITING
Acetazolamide Per os for Decompensation of Heart FailureNCT05802849 · 2023-05-01
RECRUITING
Acetazolamide for Treatment Resistant SchizophreniaNCT04887792 · 2022-02-01
RECRUITING
ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.NCT07737964 · 2026-10-01
NOT_YET_RECRUITING
Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure PatientsNCT06535529 · 2024-08-24
UNKNOWN
Efficacy and Safety of Combination Diuretic Therapy in Patients With Acute Decompensated Heart Failure and Volume OverloadNCT06414759 · 2024-07-01
UNKNOWN
Carbonic Anhydrase Inhibitors and Carbonation: A Novel Approach to Reduce Soda ConsumptionNCT06110078 · 2024-01-18
UNKNOWN
Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart FailureNCT05940220 · 2023-12-30
UNKNOWN
Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic ResistanceNCT05986773 · 2023-10-10
TERMINATED
Acetazolamide in Persons With Type 1 Diabetes - Dose FindingNCT05473364 · 2023-03-20
COMPLETED
Acetazolamide to Prevent Impending Altitude-illness in Patients With COPDNCT04913389 · 2021-06-01
UNKNOWN
Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High AltitudeNCT04915365 · 2021-05-01
UNKNOWN
Surgical Idiopathic Intracranial Hypertension Treatment TrialNCT03501966 · 2019-02-06
TERMINATED
Acetazolamide in Decompensated Heart Failure With Volume OveRload (ADVOR)NCT03505788 · 2018-11-11
COMPLETED
Acetazolamide in Patients With Acute Heart FailureNCT03720288 · 2018-10-01
UNKNOWN
Impact of Acetazolamide in Reducing Referred Postoperative PainNCT04470843 · 2018-08-22
COMPLETED
Acute Hemodynamic Effect of Acetazolamide in Pulmonary HypertensionNCT02755259 · 2017-01-01
COMPLETED
Chronic Clinical Effect of AcetazolamideNCT02755298 · 2016-10-01
COMPLETED
Augmenting Cerebral Blood Flow to Treat Established Multiple SclerosisNCT02466074 · 2016-08-17
TERMINATED
AZ, MZ, and the Pulmonary System Response to HypoxiaNCT02760121 · 2016-05-01
COMPLETED
Effect of Acetazolamide on Optic Nerve Sheath Diameter in Laparoscopic Donor NephrectomiesNCT03005665 · 2016-02-01
COMPLETED
Stop Retinal Ganglion Cell Dysfunction StudyNCT02390284 · 2015-09-01
TERMINATED
A Short Term Open, Randomized Cross-over Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension and Vascular DysfunctionNCT02220803 · 2014-03-01
COMPLETED
Treatment of Metabolic Alkalosis With Acetazolamide. Effect on the Length of Mechanical Ventilation.NCT01499485 · 2011-11-01
COMPLETED
Effectiveness of Acetazolamide for Reversal of Metabolic Alkalosis in Mechanically Ventilated Chronic Obstructive Pulmonary Disease PatientsNCT01627639 · 2011-10-01
COMPLETED
Predicting Successful Sleep Apnea Treatment With Acetazolamide in Heart Failure PatientsNCT01377987 · 2011-08-01
COMPLETED
Idiopathic Intracranial Hypertension Treatment TrialNCT01003639 · 2010-01-01
COMPLETED
Buspirone as a Potential Treatment for Recurrent Central ApneaNCT00746954 · 2008-09-01
TERMINATED
Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal BevacizumabNCT00864838 · 2008-06-01
COMPLETED
Immediate Anterior Chamber Paracentesis With A 30-Gauge Needle for Acute Primary Angle - ClosureNCT01923454 · 2005-12-01
COMPLETED

Common conditions

Trial status mix

COMPLETED14
RECRUITING7
UNKNOWN7
TERMINATED5
NOT_YET_RECRUITING1

Phase mix

PHASE313
PHASE210
PHASE47
NA5
PHASE13
EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.